Skip to main content

Vegzelma 100 mg/4 mL (25 mg/mL) injection Images

Generic Name: bevacizumab

This medication has been identified as Vegzelma 100 mg/4 mL (25 mg/mL) injection. It is supplied by Celltrion, Inc.

Vegzelma is used in the treatment of Glioblastoma Multiforme; Colorectal Cancer; Cervical Cancer; Fallopian Tube Cancer; Non-Small Cell Lung Cancer and belongs to the drug class VEGF/VEGFR inhibitors. Risk cannot be ruled out during pregnancy. Vegzelma 100 mg/4 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Vegzelma 100 mg/4 mL (25 mg/mL) injection medicine

Vegzelma

Generic Name
bevacizumab
Strength
100 mg/4 mL (25 mg/mL) injection
Availability
Prescription only
Drug Class
VEGF/VEGFR inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celltrion, Inc.
National Drug Code (NDC)
32228-0011

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.